The Role of Troponin in the Diagnosis and Treatment of Acute Pulmonary Embolism: Mechanisms of Elevation, Prognostic Evaluation, and Clinical Decision-Making
- PMID: 39328637
- PMCID: PMC11426936
- DOI: 10.7759/cureus.67922
The Role of Troponin in the Diagnosis and Treatment of Acute Pulmonary Embolism: Mechanisms of Elevation, Prognostic Evaluation, and Clinical Decision-Making
Abstract
Acute pulmonary embolism (APE) is a cardiovascular disease with severe consequences, wherein cardiac troponin (Tn) plays a pivotal role in diagnosis and treatment. This article reviews the various roles of Tn in managing APE. It looks at how Tn levels increase, their importance in predicting outcomes, and their use in making clinical decisions. Studies indicate that an elevation in Tn is primarily associated with right ventricular overload, ischemia, and necrosis, changes that directly reflect the extent of right ventricular dysfunction and myocardial injury. Elevated levels of Tn are significantly correlated with both short-term and long-term mortality risks in patients with APE, serving as crucial indicators for prognostic assessment and guiding therapeutic strategies. International guidelines recommend integrating Tn testing with clinical scoring and echocardiography to optimize treatment decisions in patients with APE. Despite the significant value of Tn determination in the management of APE, further research is needed to standardize its application. This paper emphasizes future research directions, including exploring the application of Tn in different patient subgroups with APE and its potential combined use with other biomarkers.
Keywords: acute pulmonary embolism; diagnosis; mechanisms; prognostic evaluation; troponin.
Copyright © 2024, Yang et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Acute pulmonary embolism: a review. Freund Y, Cohen-Aubart F, Bloom B. JAMA. 2022;328:1336–1345. - PubMed
-
- Management of acute pulmonary embolism. Paul JD, Cifu AS. JAMA. 2020;324:597–598. - PubMed
-
- Global Burden of thrombosis: epidemiologic aspects. Wendelboe AM, Raskob GE. Circ Res. 2016;118:1340–1347. - PubMed
-
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Konstantinides SV, Meyer G, Becattini C, et al. Eur Heart J. 2020;41:543–603. - PubMed
-
- Risk stratification and risk-adapted management of acute pulmonary embolism. Kohls N, Konstantinides SV, Lang IM, Funk GC, Huber K. Wien Klin Wochenschr. 2023;135:22–27. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous